Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Chinese Patent Office
Johnson and Johnson
Merck
Argus Health
Colorcon

Generated: June 18, 2019

DrugPatentWatch Database Preview

Profile for Australia Patent: 2005299253

« Back to Dashboard

US Patent Family Members and Approved Drugs for Australia Patent: 2005299253

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
➤ Try a Free Trial Feb 3, 2028 Mayne Pharma DORYX doxycycline hyclate
➤ Try a Free Trial Feb 3, 2028 Mayne Pharma DORYX MPC doxycycline hyclate
US Patent Number US Expiration Date US Applicant US Tradename Generic Name

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Chubb
Argus Health
Federal Trade Commission
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.